The device is the only product cleared by the Food and Drug Administration as a stand-alone interbody fusion device that expands in-situ for minimally invasive procedures. The device can be used for single or two contiguous levels in the lumbar spine during transforaminal and anterior lumbar interbody fusion.
The system includes the VariLift-C, a device designed for cervical spine surgery applications, which has the CE Mark approval in Europe.
Related Articles on Wenzel Spine:
Wenzel Spine Hires Jon Luedke as Executive Vice President
Wenzel Spine Launches Multimedia Profiles
Wenzel Spine Receives FDA Clearance on Spinal System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.